Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

Women with mutations of the genes BRCA1 or BRCA2 are at increased risk of ovarian cancer. Oral contraceptives protect against ovarian cancer in general, but it is not known whether they protect against the disease in carriers of these mutations. We obtained self-reported lifetime histories of oral c...

Descripción completa

Detalles Bibliográficos
Autores principales: Whittemore, A S, Balise, R R, Pharoah, P D P, DiCioccio, R A, Oakley-Girvan, I, Ramus, S J, Daly, M, Usinowicz, M B, Garlinghouse-Jones, K, Ponder, B A J, Buys, S, Senie, R, Andrulis, I, John, E, Hopper, J L, Piver, M S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410144/
https://www.ncbi.nlm.nih.gov/pubmed/15545966
http://dx.doi.org/10.1038/sj.bjc.6602239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410144/
https://www.ncbi.nlm.nih.gov/pubmed/15545966
http://dx.doi.org/10.1038/sj.bjc.6602239

Ejemplares similares